These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 10602488

  • 1. Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt.
    del Peso L, González VM, Hernández R, Barr FG, Núñez G.
    Oncogene; 1999 Dec 02; 18(51):7328-33. PubMed ID: 10602488
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.
    Abid MR, Guo S, Minami T, Spokes KC, Ueki K, Skurk C, Walsh K, Aird WC.
    Arterioscler Thromb Vasc Biol; 2004 Feb 02; 24(2):294-300. PubMed ID: 14656735
    [Abstract] [Full Text] [Related]

  • 3. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
    Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME.
    Mol Cell Biol; 2001 Feb 02; 21(3):952-65. PubMed ID: 11154281
    [Abstract] [Full Text] [Related]

  • 4. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
    Barr FG.
    Oncogene; 2001 Sep 10; 20(40):5736-46. PubMed ID: 11607823
    [Abstract] [Full Text] [Related]

  • 5. Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins.
    Richards JS, Sharma SC, Falender AE, Lo YH.
    Mol Endocrinol; 2002 Mar 10; 16(3):580-99. PubMed ID: 11875118
    [Abstract] [Full Text] [Related]

  • 6. Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene.
    Ayyanathan K, Fredericks WJ, Berking C, Herlyn M, Balakrishnan C, Gunther E, Rauscher FJ.
    Cancer Res; 2000 Oct 15; 60(20):5803-14. PubMed ID: 11059777
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional regulation of neuronal genes and its effect on neural functions: expression and function of forkhead transcription factors in neurons.
    Fukunaga K, Ishigami T, Kawano T.
    J Pharmacol Sci; 2005 Jul 15; 98(3):205-11. PubMed ID: 16006742
    [Abstract] [Full Text] [Related]

  • 8. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains.
    Bennicelli JL, Fredericks WJ, Wilson RB, Rauscher FJ, Barr FG.
    Oncogene; 1995 Jul 06; 11(1):119-30. PubMed ID: 7624119
    [Abstract] [Full Text] [Related]

  • 9. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
    Sublett JE, Jeon IS, Shapiro DN.
    Oncogene; 1995 Aug 03; 11(3):545-52. PubMed ID: 7630639
    [Abstract] [Full Text] [Related]

  • 10. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3.
    Fredericks WJ, Galili N, Mukhopadhyay S, Rovera G, Bennicelli J, Barr FG, Rauscher FJ.
    Mol Cell Biol; 1995 Mar 03; 15(3):1522-35. PubMed ID: 7862145
    [Abstract] [Full Text] [Related]

  • 11. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting.
    Rena G, Prescott AR, Guo S, Cohen P, Unterman TG.
    Biochem J; 2001 Mar 15; 354(Pt 3):605-12. PubMed ID: 11237865
    [Abstract] [Full Text] [Related]

  • 12. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.
    Khan J, Bittner ML, Saal LH, Teichmann U, Azorsa DO, Gooden GC, Pavan WJ, Trent JM, Meltzer PS.
    Proc Natl Acad Sci U S A; 1999 Nov 09; 96(23):13264-9. PubMed ID: 10557309
    [Abstract] [Full Text] [Related]

  • 13. PAX3-FKHR transformation increases 26 S proteasome-dependent degradation of p27Kip1, a potential role for elevated Skp2 expression.
    Zhang L, Wang C.
    J Biol Chem; 2003 Jan 03; 278(1):27-36. PubMed ID: 12401804
    [Abstract] [Full Text] [Related]

  • 14. The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain.
    Lam PY, Sublett JE, Hollenbach AD, Roussel MF.
    Mol Cell Biol; 1999 Jan 03; 19(1):594-601. PubMed ID: 9858583
    [Abstract] [Full Text] [Related]

  • 15. Tumor-specific PAX3-FKHR transcription factor, but not PAX3, activates the platelet-derived growth factor alpha receptor.
    Epstein JA, Song B, Lakkis M, Wang C.
    Mol Cell Biol; 1998 Jul 03; 18(7):4118-30. PubMed ID: 9632796
    [Abstract] [Full Text] [Related]

  • 16. A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma.
    Kempf BE, Vogt PK.
    Cell Growth Differ; 1999 Dec 03; 10(12):813-8. PubMed ID: 10616906
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation.
    Furuyama T, Kitayama K, Yamashita H, Mori N.
    Biochem J; 2003 Oct 15; 375(Pt 2):365-71. PubMed ID: 12820900
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.